학술논문

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 2023, 7(22):7141-7150)
Subject
Language
English
ISSN
24739537
24739529